ZANTAC 300 Glaxo (Zantac 300 300 mg)
Generic Name: ranitidine
Pill with imprint ZANTAC 300 Glaxo is Yellow, Elliptical / Oval and has been identified as Zantac 300 300 mg. It is supplied by GlaxoSmithKline.
Zantac 300 is used in the treatment of duodenal ulcer; erosive esophagitis; gerd; duodenal ulcer prophylaxis; gastric ulcer maintenance treatment and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Zantac 300 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ZANTAC 300 Glaxo
Zantac 300
- Generic Name
- ranitidine
- Imprint
- ZANTAC 300 Glaxo
- Strength
- 300 mg
- Color
- Yellow
- Size
- 16.00 mm
- Shape
- Elliptical / Oval
- Availability
- Rx and/or OTC
- Drug Class
- H2 antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- GlaxoSmithKline
- Inactive Ingredients
-
croscarmellose sodium, D&C Yellow No. 10, magnesium stearate, microcrystalline cellulose, titanium dioxide, triacetin
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00173-0393 | GlaxoSmithKline |
| 52959-0201 | H.J. Harkins Company, Inc. (repackager) |
Related Images for "ZANTAC 300 Glaxo"
More about Zantac 300 (ranitidine)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- 3 Reviews
- Generic Availability
- Drug class: H2 antagonists
- FDA Alerts (18)
Professional resources
Other Formulations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
